Variant report
Variant | nsv521522 |
---|---|
Chromosome Location | chr8:4258195-4262526 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1430449 | chr8:4258195-4258196 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186963386 | chr8:4258200-4258201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200201744 | chr8:4258212-4258213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528473825 | chr8:4258239-4258240 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191305549 | chr8:4258254-4258255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559373910 | chr8:4258278-4258279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11439463 | chr8:4258283-4258284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72483538 | chr8:4258284-4258285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs66541453 | chr8:4258296-4258297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200106188 | chr8:4258298-4258299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200664073 | chr8:4258300-4258301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs13281118 | chr8:4258315-4258316 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs573005342 | chr8:4258343-4258344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147078323 | chr8:4258371-4258372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530557861 | chr8:4258377-4258378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531492610 | chr8:4258382-4258383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548799966 | chr8:4258415-4258416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372972604 | chr8:4258422-4258423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183473356 | chr8:4258427-4258428 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534306995 | chr8:4258431-4258432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553643553 | chr8:4258441-4258442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376088718 | chr8:4258458-4258459 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539238013 | chr8:4258459-4258460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557548714 | chr8:4258472-4258473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112879294 | chr8:4258484-4258485 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201565986 | chr8:4258485-4258486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575900854 | chr8:4258510-4258511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188871104 | chr8:4258519-4258520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193221404 | chr8:4258543-4258544 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573225913 | chr8:4258553-4258554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540233047 | chr8:4258559-4258560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138506413 | chr8:4258572-4258573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533015290 | chr8:4258594-4258595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185501906 | chr8:4258607-4258608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571564988 | chr8:4258609-4258610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75061078 | chr8:4258610-4258611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557811990 | chr8:4258621-4258622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530594932 | chr8:4258648-4258649 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540290068 | chr8:4258654-4258655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534122450 | chr8:4258658-4258659 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79079799 | chr8:4258665-4258666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190354486 | chr8:4258670-4258671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528111065 | chr8:4258673-4258674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546231864 | chr8:4258681-4258682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181592692 | chr8:4258683-4258684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73658847 | chr8:4258686-4258687 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs144404720 | chr8:4258774-4258775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569517979 | chr8:4258776-4258777 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184318488 | chr8:4258791-4258792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536433843 | chr8:4258792-4258793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Schizophrenia | 21346763 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4257600-4260400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr8:4257800-4258200 | Enhancers | Fetal Brain Male | brain |
3 | chr8:4258000-4260000 | Weak transcription | Fetal Brain Female | brain |
4 | chr8:4258200-4265000 | Weak transcription | Fetal Brain Male | brain |
5 | chr8:4259600-4259800 | Enhancers | Fetal Heart | heart |
6 | chr8:4259800-4260200 | Enhancers | Brain Germinal Matrix | brain |
7 | chr8:4259800-4260400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr8:4260000-4260200 | Enhancers | Fetal Brain Female | brain |
9 | chr8:4260200-4263200 | Weak transcription | Brain Germinal Matrix | brain |
10 | chr8:4260400-4263200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
11 | chr8:4260400-4264200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |